Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hepatitis B Immune Globulin I.V. Approval Could Rely On Open-Label Studies, Historical Controls – FDA

This article was originally published in The Pink Sheet Daily

Executive Summary

The agency's briefing materials for the March 18 meeting of the Blood Products Advisory Committee note that prospective trials could be difficult because HBIGIV is currently used off-label in combination with antiviral drugs.

You may also be interested in...



Nabi-HB Decision Anticipated “Shortly” Following FDA Advisory Committee Review

FDA’s Blood Products Advisory Committee recommended approval of Nabi’s BLA for the treatment of liver transplant patients.

Nabi-HB Decision Anticipated “Shortly” Following FDA Advisory Committee Review

FDA’s Blood Products Advisory Committee recommended approval of Nabi’s BLA for the treatment of liver transplant patients.

Biopure’s Hemopure BPAC Review To Be Closed-Door

The day before Biopure's July 14 review, FDA's Blood Products Advisory Committee will discuss Nabi's Nabi-HB immunoglobulin for hepatitis B.

Related Content

Topics

UsernamePublicRestriction

Register

LL111109

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel